Advertisement

Menopause

Published:December 27, 2022DOI:https://doi.org/10.1016/j.mcna.2022.10.003

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Medical Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • McKinlay S.M.
        • Brambilla D.J.
        • Posner J.G.
        The normal menopause transition.
        Maturitas. 1992; 14: 103-115
        • Harlow S.D.
        • Gass M.
        • Hall J.E.
        • et al.
        Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.
        J Clin Endocrinol Metab. 2012; 97: 1159-1168
        • Tepper P.G.
        • Brooks M.M.
        • Randolph Jr., J.F.
        • et al.
        Characterizing the trajectories of vasomotor symptoms across the menopausal transition.
        Menopause. 2016; 23: 1067-1074
        • Moral E.
        • Delgado J.L.
        • Carmona F.
        • et al.
        Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study.
        Climacteric. 2018; 21: 167-173
        • Avis N.E.
        • Brambilla D.
        • McKinlay S.M.
        • et al.
        A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women's Health Study.
        Ann Epidemiol. 1994; 4: 214-220
        • Kravitz H.M.
        • Ganz P.A.
        • Bromberger J.
        • et al.
        Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition.
        Menopause. 2003; 10: 19-28
        • Sullivan Mitchell E.
        • Fugate Woods N.
        Midlife women's attributions about perceived memory changes: observations from the Seattle Midlife Women's Health Study.
        J Womens Health Gend Based Med. 2001; 10: 351-362
        • Greendale G.A.
        • Sowers M.
        • Han W.
        • et al.
        Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women's Health Across the Nation (SWAN).
        J Bone Miner Res. 2012; 27: 111-118
        • Nelson H.D.
        • Haney E.
        • Humphrey L.
        • et al.
        Management of menopause-related symptoms.
        Evid Rep Technol Assess (Summ). 2005; 120 (Available at:): 1-6
        • Furness S.
        • Roberts H.
        • Marjoribanks J.
        • et al.
        Hormone therapy in postmenopausal women and risk of endometrial hyperplasia.
        Cochrane Database Syst Rev. 2012; 8: CD000402
        • Rossouw J.E.
        • Anderson G.L.
        • Prentice R.L.
        • et al.
        Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
        JAMA. 2002; 288: 321-333
        • Rossouw J.E.
        • Prentice R.L.
        • Manson J.E.
        • et al.
        Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.
        JAMA. 2007; 297: 1465-1477
        • The NHTPSAP
        The 2017 hormone therapy position statement of The North American Menopause Society.
        Menopause. 2017; 24: 728-753
        • Manson J.E.
        • Aragaki A.K.
        • Rossouw J.E.
        • et al.
        Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials.
        JAMA. 2017; 318: 927-938
        • Chlebowski R.T.
        • Anderson G.L.
        • Aragaki A.K.
        • et al.
        Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.
        JAMA. 2020; 324: 369-380
        • Boardman H.M.
        • Hartley L.
        • Eisinga A.
        • et al.
        Hormone therapy for preventing cardiovascular disease in post-menopausal women.
        Cochrane Database Syst Rev. 2015; : CD002229https://doi.org/10.1002/14651858.CD002229.pub4
        • Vinogradova Y.
        • Coupland C.
        • Hippisley-Cox J.
        Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.
        BMJ. 2019; 364: k4810
        • Chen W.Y.
        • Manson J.E.
        • Hankinson S.E.
        • et al.
        Unopposed estrogen therapy and the risk of invasive breast cancer.
        Arch Intern Med. 2006; 166: 1027-1032
        • Manson J.E.
        • Chlebowski R.T.
        • Stefanick M.L.
        • et al.
        Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.
        JAMA. 2013; 310: 1353-1368
        • Collaborative Group on Hormonal Factors in Breast C.
        Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
        Lancet. 2019; 394: 1159-1168
        • Shifren J.L.
        • Crandall C.J.
        • Manson J.E.
        Menopausal Hormone Therapy.
        JAMA. 2019; 321: 2458-2459
        • Mattson R.H.
        • Cramer J.A.
        • Darney P.D.
        • et al.
        Use of oral contraceptives by women with epilepsy.
        JAMA. 1986; 256 (Available at:): 238-240
        • Pinkerton J.V.
        • Faubion S.S.
        • Kaunitz A.M.
        • et al.
        The National Academies of Science, Engineering, and Medicine (NASEM) Report on Compounded Bioidentical Hormone Therapy.
        Menopause. 2020; 27: 1199-1201
        • Haskell S.G.
        • Bean-Mayberry B.
        • Gordon K.
        Discontinuing postmenopausal hormone therapy: an observational study of tapering versus quitting cold turkey: is there a difference in recurrence of menopausal symptoms?.
        Menopause. 2009; 16: 494-499
        • North American Menopause S.
        The North American Menopause Society Statement on Continuing Use of Systemic Hormone Therapy After Age 65.
        Menopause. 2015; 22: 693
        • Stearns V.
        • Beebe K.L.
        • Iyengar M.
        • et al.
        Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial.
        JAMA. 2003; 289: 2827-2834
        • Barton D.L.
        • LaVasseur B.I.
        • Sloan J.A.
        • et al.
        Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9.
        J Clin Oncol. 2010; 28: 3278-3283
        • Freeman E.W.
        • Guthrie K.A.
        • Caan B.
        • et al.
        Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.
        JAMA. 2011; 305: 267-274
        • Loprinzi C.L.
        • Kugler J.W.
        • Sloan J.A.
        • et al.
        Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial.
        Lancet. 2000; 356: 2059-2063
        • Pinkerton J.V.
        • Constantine G.
        • Hwang E.
        • et al.
        Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial.
        Menopause. 2013; 20: 28-37
        • Rada G.
        • Capurro D.
        • Pantoja T.
        • et al.
        Non-hormonal interventions for hot flushes in women with a history of breast cancer.
        Cochrane Database Syst Rev. 2010; 9: CD004923
        • Shams T.
        • Firwana B.
        • Habib F.
        • et al.
        SSRIs for hot flashes: a systematic review and meta-analysis of randomized trials.
        J Gen Intern Med. 2014; 29: 204-213
        • Brown J.N.
        • Wright B.R.
        Use of gabapentin in patients experiencing hot flashes.
        Pharmacotherapy. 2009; 29: 74-81
        • Hayes L.P.
        • Carroll D.G.
        • Kelley K.W.
        Use of gabapentin for the management of natural or surgical menopausal hot flashes.
        Ann Pharmacother. 2011; 45: 388-394
        • Reddy S.Y.
        • Warner H.
        • Guttuso Jr., T.
        • et al.
        Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial.
        Obstet Gynecol. 2006; 108: 41-48
        • Pandya K.J.
        • Raubertas R.F.
        • Flynn P.J.
        • et al.
        Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study.
        Ann Intern Med. 2000; 132: 788-793
        • Newton K.M.
        • Buist D.S.
        • Keenan N.L.
        • et al.
        Use of alternative therapies for menopause symptoms: results of a population-based survey.
        Obstet Gynecol. 2002; 100: 18-25
        • Mann E.
        • Smith M.
        • Hellier J.
        • et al.
        A randomised controlled trial of a cognitive behavioural intervention for women who have menopausal symptoms following breast cancer treatment (MENOS 1): trial protocol.
        BMC Cancer. 2011; 11: 44
        • Ayers B.
        • Smith M.
        • Hellier J.
        • et al.
        Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized controlled trial.
        Menopause. 2012; 19: 749-759
        • Elkins G.R.
        • Fisher W.I.
        • Johnson A.K.
        • et al.
        Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial.
        Menopause. 2013; 20: 291-298
        • Carmody J.F.
        • Crawford S.
        • Salmoirago-Blotcher E.
        • et al.
        Mindfulness training for coping with hot flashes: results of a randomized trial.
        Menopause. 2011; 18: 611-620
        • Walega D.R.
        • Rubin L.H.
        • Banuvar S.
        • et al.
        Effects of stellate ganglion block on vasomotor symptoms: findings from a randomized controlled clinical trial in postmenopausal women.
        Menopause. 2014; 21: 807-814
        • Huang A.J.
        • Subak L.L.
        • Wing R.
        • et al.
        An intensive behavioral weight loss intervention and hot flushes in women.
        Arch Intern Med. 2010; 170: 1161-1167
        • Franco O.H.
        • Chowdhury R.
        • Troup J.
        • et al.
        Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis.
        JAMA. 2016; 315: 2554-2563